---
title: 'In vivo dosimetry for proton therapy: A Monte Carlo study of the Gadolinium
  spectral response throughout the course of treatment'
date: '2025-01-22'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39838583/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250122171154&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: The study suggests that the spectral response of a Gd-based
  contrast agent can be used for in vivo dosimetry, providing insights into the TP
  delivery. The Gd 43 keV spectral line was correlated with the dose at the tumor,
  its volume, and its position. Other variables that can impact the method, such as
  the kinetic energy of the incident protons and Gd concentration in the target were
  also ...'
disable_comments: true
---
CONCLUSIONS: The study suggests that the spectral response of a Gd-based contrast agent can be used for in vivo dosimetry, providing insights into the TP delivery. The Gd 43 keV spectral line was correlated with the dose at the tumor, its volume, and its position. Other variables that can impact the method, such as the kinetic energy of the incident protons and Gd concentration in the target were also ...